Financial Statements — SVRE
Balance Sheet
(in millions ILS)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 15.99 | 11.30 | 14.77 | 41.08 |
| Inventory | 4.14 | 5.76 | 3.45 | 0.86 |
| Total Current Assets | 22.62 | 19.60 | 24.81 | 43.26 |
| Total Non-current Assets | 1.90 | 2.44 | 0.81 | 1.19 |
| Total Assets | 24.53 | 22.04 | 25.62 | 44.45 |
| Total Current Liabilities | 6.50 | 10.82 | 15.10 | 9.02 |
| Total Non-current Liabilities | 1.22 | 1.60 | 0.97 | 1.57 |
| Total Liabilities* | 7.72 | 12.42 | 16.07 | 10.59 |
| Retained Earnings | (186.67) | (151.89) | (119.53) | (88.71) |
| Total Stockholder Equity | 16.81 | 9.62 | 9.55 | 33.86 |
* Derived from reported values
Income Statement
(in millions ILS) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Total Revenue | 0.76 | 0.48 | 1.48 | 0.38 |
| Cost of Revenue* | 0.53 | 0.40 | 1.01 | 0.27 |
| Gross Profit | 0.22 | 0.09 | 0.47 | 0.12 |
| Research & Development | 9.84 | 8.90 | 12.19 | 10.18 |
| Selling, General & Admin | 4.74 | 4.46 | 4.47 | 2.51 |
| Total Operating Expenses* | 17.01 | 15.76 | 18.11 | 13.18 |
| Operating Income | (16.78) | (15.68) | (17.64) | (13.06) |
| Net Income | (16.12) | (16.28) | (17.75) | (11.90) |
| Basic EPS | (0.01) | (0.21) | (0.64) | (1.15) |
| Diluted EPS | (0.01) | (0.21) | (0.64) | (1.15) |
* Derived from reported values
Cash Flow Statement
(in millions ILS)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (15.37) | (16.32) | (17.97) | (11.91) |
| Investing Cash Flow | (0.01) | (0.01) | 6.19 | 5.00 |
| Financing Cash Flow | 19.83 | 10.41 | 7.12 | 37.34 |
